ShopSpell

Drugs Targeting B-Cells in Autoimmune Diseases [Hardcover]

$125.99     $169.99    26% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  3034807058
  • ISBN-10:  3034807058
  • ISBN-13:  9783034807050
  • ISBN-13:  9783034807050
  • Publisher:  Springer
  • Publisher:  Springer
  • Pages:  300
  • Pages:  300
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Feb-2013
  • Pub Date:  01-Feb-2013
  • SKU:  3034807058-11-SPRI
  • SKU:  3034807058-11-SPRI
  • Item ID: 100761858
  • List Price: $169.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 14 to Jul 16
  • Notes: Brand New Book. Order Now.

This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sj?gren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.

This book offers a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sj?gren syndrome, ANCA-associated vasculitis and cryoglobulinemia.

Historic outline of the development of drugs targeting B-cells.- Understanding B-cell biology.- Pharmacological effects and mechanisms of action of agents blocking B cells.- Systemic lupus erythematosus: direct B-cell blocking.- Systemic lupus erythematosus: indirect B-cell blocking.- B-cell targeted therapies in rheumatoid arthritis.- B-cell targeted therapies in Primary Sj?gren Syndrome.- Targeting B cells in ANCA-associated vasculitis.- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies.- B-cell targeted therapies in cryoglobulinemia.- B-cell targeted therapies in autoimmune cytopenias and thrombosis.- Targeting B cells in neurological autoimmune diseases.- Targeting B cells in other systemic autoimmune diseases.- Safety of B-cell targeted therapies.- The future potential of biosimilars targeting B-cells.

This book prolS,

Add Review